Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.78%
1,091.52
+8.48
+0.78%
—1,083.041,082.631,094.711,080.59——
SIXC
Communications
SIXC
Communications
SIXC
+0.26%
603.95
+1.57
+0.26%
—602.38602.38604.24599.75——
SIXE
Energy
SIXE
Energy
SIXE
+0.43%
1,248.15
+5.32
+0.43%
—1,242.831,229.311,251.791,220.51——
SIXI
Industrials
SIXI
Industrials
SIXI
+2.01%
1,748.23
+34.33
+2.01%
—1,713.821,715.471,754.201,715.47——
SIXM
Financials
SIXM
Financials
SIXM
+0.17%
641.07
+1.08
+0.17%
—639.99636.98642.82631.81——
SIXR
Staples
SIXR
Staples
SIXR
+1.16%
847.18
+9.72
+1.16%
—837.46840.30852.15840.30——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.09%
216.55
+2.33
+1.09%
—214.22214.22217.26214.05——
SIXT
Technology
SIXT
Technology
SIXT
-0.32%
3,194.13
-10.25
-0.32%
—3,204.383,215.043,215.043,159.90——
SIXU
Utilities
SIXU
Utilities
SIXU
+1.66%
940.78
+15.40
+1.66%
—925.38927.91948.11927.91——
SIXV
Health care
SIXV
Health care
SIXV
+1.74%
1,467.85
+25.14
+1.74%
—1,442.711,443.011,476.181,443.01——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.36%
2,369.79
+8.45
+0.36%
—2,361.342,391.002,395.822,354.52——
4549:TYO
Eiken Chemical Co Ltd
¥3,080.00
-0.81%
(-25.00) 1D
Apr 30, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4549...
Open
¥3,065
High
¥3,130
Low
¥3,065
Mkt. cap
106.39B
Avg. vol.
161.28K
Volume
151.60K
Dividend
1.82%
Quarterly dividend
¥14
Ex dividend date
Sep 29, 2025
P/E ratio
26.54
52-wk high
¥3,500
52-wk low
¥1,972
EPS
¥116
Shares outstanding
36.88M
No. of employees
702
News stories
From sources across the web
Profile
Eiken Chemical is a Japanese company headquartered in Tokyo, established in 1939. The company's business is manufacturing and sales of clinical diagnostics and equipment. Eiken's major products include fecal immunochemical test reagents, immunological and serological reagents, microbiological reagents, urinalysis test strips, clinical chemistry reagents, molecular genetics, medical devices and industrial products. The company in 1998 developed the Loop-mediated isothermal amplification method, a nucleic acid amplification method, and an alternative to traditional PCR. Wikipedia
About Eiken Chemical Co Ltd
CEOMorifumi Wada
Employees702
FoundedFeb 20, 1939
Headquarters-
SectorMedical device
Websiteeiken.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
9.90B
10.20B
10.23B
10.95B
Cost of goods sold
6.16B
6.09B
5.96B
6.70B
Cost of revenue
6.16B
6.09B
5.96B
6.70B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.37B
3.30B
3.34B
3.20B
Operating expense
3.37B
3.30B
3.34B
3.20B
Total operating expenses
9.54B
9.40B
9.30B
9.90B
Operating income
364.00M
801.00M
928.00M
1.05B
Other non operating income
51.00M
34.00M
6.00M
-54.00M
EBT including unusual items
114.00M
814.00M
2.91B
1.00B
EBT excluding unusual items
364.00M
814.00M
915.00M
995.00M
Income tax expense
2.00M
214.00M
535.00M
260.00M
Effective tax rate
1.75%
26.29%
18.36%
25.92%
Other operating expenses
-
-
-
-
Net income
112.00M
600.00M
2.38B
743.00M
Net profit margin
1.13%
5.88%
23.25%
6.79%
Earnings per share
-
-
-
-
Interest and investment income
4.00M
4.00M
8.00M
4.00M
Interest expense
-5.00M
-4.00M
-5.00M
-5.00M
Net interest expenses
-1.00M
-
3.00M
-1.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
935.50M
1.37B
1.50B
1.62B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer